Alzheimer's disease and Alzheimer's dementia: distinct but overlapping entities

被引:51
作者
Blass, JP [1 ]
机构
[1] Cornell Univ, Coll Med, Burke Med Res Inst, White Plains, NY 10605 USA
关键词
Alzheimer disease; Alzheimer dementia; causes;
D O I
10.1016/S0197-4580(02)00036-2
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Much of the controversy about the "amyloid cascade hypothesis" may reflect unrecognized differences in the use of language, including the use of the word "cause." This commentary proposes that the term Alzheimer disease refer to the neuropathological entity and the term Alzheimer dementia to clinical dementia in people who also have Alzheimer neuropathology. The ultimate causes of Alzheimer disease are proposed to be aging, environmental stresses, and genetic predispositions. The fundamental cause of Alzheimer dementia is proposed to be Alzheimer disease, i.e. the neurobiological abnormalities in Alzheimer brain. The neurobiology of Alzheimer disease includes changes that may initially be adaptive but can become excessive and thereby harmful; they include increased expression of APP with accumulation of potentially damaging peptides such as Abeta, inflammation, and increased ROS activity. The neurobiological abnormality that is the proximate cause of Alzheimer dementia appears to be decreases in cerebral metabolic rate. Decreased metabolism occurs not only in. this but in essentially all dementias, and impairing brain metabolism induces neuropsychological deficits characteristic of dementias. The immediate cause of Alzheimer dementia is proposed to be deficiencies in signaling, both intracellular and intercellular (neurotransmission), that follow directly from the decrease in cerebrometabolic rate. (C) 2002 Published by Elsevier Science Inc.
引用
收藏
页码:1077 / 1084
页数:8
相关论文
共 58 条
  • [1] Oxidative modification of glutamine synthetase by amyloid beta peptide
    Aksenov, MY
    Aksenova, MV
    Carney, JM
    Butterfield, DA
    [J]. FREE RADICAL RESEARCH, 1997, 27 (03) : 267 - 281
  • [2] [Anonymous], 1997, Neurobiol Aging, V18, pS1
  • [3] Immunologic treatment of Alzheimer's disease
    Blass, JP
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (22) : 1694 - 1695
  • [4] Brain metabolism and brain disease: Is metabolic deficiency the proximate cause of Alzheimer dementia?
    Blass, JP
    [J]. JOURNAL OF NEUROSCIENCE RESEARCH, 2001, 66 (05) : 851 - 856
  • [5] Blass JP, 2000, ANN NY ACAD SCI, V924, P170
  • [6] Cerebrometabolic aspects of delirium in relationship to dementia
    Blass, JP
    Gibson, GE
    [J]. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 1999, 10 (05) : 335 - 338
  • [7] Inherent abnormalities in energy metabolism in Alzheimer disease - Interaction with cerebrovascular compromise
    Blass, JP
    Sheu, RKF
    Gibson, GE
    [J]. VASCULAR FACTORS IN ALZHEIMER'S DISEASE, 2000, 903 : 204 - 221
  • [8] BLASS JP, 2002, IN PRESS METABOLIC E
  • [9] BLASS JP, 1983, NEUROLOGY AGING, P189
  • [10] Correlation of the clinical severity of Alzheimer's disease with an aberration in mitochondrial DNA (antDNA)
    Brown, AM
    Sheu, RKF
    Mohs, R
    Haroutunian, V
    Blass, JP
    [J]. JOURNAL OF MOLECULAR NEUROSCIENCE, 2001, 16 (01) : 41 - 48